Clinical Outcomes of Rivaroxaban versus LMWH Thromboprophylaxis Following Gynecologic Cancer Surgery: A Retrospective Comparison Study
International Journal of Women's Health · 2026-11 · Volume 18 · 1-8
DOI: 10.2147/ijwh.s648285 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Women's Health, 2026-11. Verfasst von Hong Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian M…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, Fujian, People's Republic of China.
ORCID-Profile: Hong Zhou, Jinhua Zhang
Zitieren
APA
Zhou, H., Wei, T., Zheng, H., & Zhang, J. (2026). Clinical Outcomes of Rivaroxaban versus LMWH Thromboprophylaxis Following Gynecologic Cancer Surgery: A Retrospective Comparison Study. International Journal of Women's Health, Volume 18, 1-8. https://doi.org/10.2147/ijwh.s648285
Vancouver
Zhou H, Wei T, Zheng H, Zhang J. Clinical Outcomes of Rivaroxaban versus LMWH Thromboprophylaxis Following Gynecologic Cancer Surgery: A Retrospective Comparison Study. International Journal of Women's Health. 2026;Volume 18:1-8. doi:10.2147/ijwh.s648285
BibTeX
@article{Zhou2026,
author = {Zhou, Hong and Wei, Ting and Zheng, Huanrui and Zhang, Jinhua},
title = {Clinical Outcomes of Rivaroxaban versus LMWH Thromboprophylaxis Following Gynecologic Cancer Surgery: A Retrospective Comparison Study},
journal = {International Journal of Women's Health},
year = {2026},
volume = {Volume 18},
pages = {1--8},
doi = {10.2147/ijwh.s648285}
}
EUVIMED